Vaccine protects mice from 1918 flu virus

Oct 17, 2006

U.S. medical researchers say they've developed a vaccine that protects mice against the killer 1918 influenza virus.

The National Institutes of Health scientists say they also have created a technique for identifying antibodies that neutralize that deadly virus, a tool that could help contain future pandemic flu strains.

The findings are important to understanding and preventing the recurrence of the H1N1 influenza virus that caused the 1918 pandemic, and for protecting against virulent flu strains in the future, including the H5N1 avian flu virus.

"Understanding why this influenza virus was so deadly is an extremely important question," said NIAID Director Dr. Anthony Fauci "By building upon earlier research where scientists successfully reconstructed the 1918 pandemic flu strain, Dr. Nabel and his colleagues have demonstrated that this virus is vulnerable to intervention.

The 1918-1919 influenza pandemic was the most deadly flu outbreak in modern history, killing 50 million or more people worldwide.

The study -- led by Dr. Gary Nabel, director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases -- appears online in the Proceedings of the National Academy of Sciences.

Copyright 2006 by United Press International

Explore further: Experts favor US approval of Merck sleeping pill (Update)

add to favorites email to friend print save as pdf

Related Stories

Pigs in southern China infected with avian flu

Dec 19, 2012

Researchers report for the first time the seroprevalence of three strains of avian influenza viruses in pigs in southern China, but not the H5N1 avian influenza virus. Their research, published online ahead of print in the ...

Recommended for you

Glaxo, US partnering to develop new antibiotics

May 22, 2013

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

New sleeping pill poised to hit US markets

May 21, 2013

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Global recommendations on child medicine

May 21, 2013

Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...

User comments : 0

More news stories

Ferrets, pigs susceptible to H7N9 avian influenza virus

Chinese and U.S. scientists have used virus isolated from a person who died from H7N9 avian influenza infection to determine whether the virus could infect and be transmitted between ferrets. Ferrets are often used as a mammalian ...

Solar Kettle allows for boiling water off the grid

(Phys.org) —A company called Contemporary Energy has unveiled a new device it calls the Solar Kettle. It looks very much like a normal coffee thermos, but has flaps on one side that open to allow for collecting ...

Scientists discover how rapamycin slows cell growth

University of Montreal researchers have discovered a novel molecular mechanism that can potentially slow the progression of some cancers and other diseases of abnormal growth. In the May 23 edition of the prestigious journal ...